EUVIMEDEUVIMED entdecken
Crossref

BREAST CANCER TREATMENT DE-ESCALATION: BREAKING THE SOUND BARRIER

Gianluca Vanni, Materazzo, M., Pellicciaro, M., Tacconi, F., Faccini, B. A., B. Longo, Cervelli, V. und 2 weitere

Cineca Institutional Research Information System (Tor Vergata University) · 01.01.2023

DOI: 10.32113/wcrj_20239_2682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cineca Institutional Research Information System (Tor Vergata University), erschienen am 01.01.2023. Verfasst von Gianluca Vanni und 13 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast Cancer (BC) is the leading oncological diagnosis, with the annual incidence expected to exceed 3 million new cases by 2040 due to population growth and ageing. Despite the increasing number of BC patients, recent advancements in multidisciplinary treatment have enabled surgical de-escalation, maintaining equivalent oncological outcomes. Areas of surgical de-escalation include avoidance of axillary lymph node dissection in patients with low disease burden, re-excision in close margins after breast conserving surgery, and even complete avoidance of surgery in selected cases. Despite the evidence supporting these de-escalation protocols, their implementation is inconsistent. The article discusses how these strategies can be further integrated into BC treatment plans to improve patients' quality of life and optimize health care resources. The future of BC management may be shaped by genomic tests, offering more tailored and potentially less invasive treatment strategies. A comprehensive understanding of tumor biology has facilitated the development of strategies such as neoadju-vant chemotherapy, with the potential to further de-escalate surgery. The need for a multidisciplinary approach to BC care, incorporating emerging diagnostic tools and understanding of individual patient's disease trajectory, is paramount. It is essential to challenge the perception of more aggressive treatments as inherently better and ensure decisions are based on high-quality evidence, preserving the principle of 'do no harm'. The focus of future BC research should be on identifying markers capable of predicting the risk of distant recurrence and implement-ing a true multidisciplinary de-escalation approach.

Schlagwörter

breast cancertreatment de-escalationaxillary lymph node dissection avoidancebreast-conserving surgeryre-excisionneoadjuvant chemotherapymultidisciplinary caregenomic testingquality of life

Zitieren

APA

Vanni, G., Materazzo, M., Pellicciaro, M., Tacconi, F., Faccini, A., B., Longo, B., Cervelli, V., Buonomo, & C., O. (2023). BREAST CANCER TREATMENT DE-ESCALATION: BREAKING THE SOUND BARRIER. Cineca Institutional Research Information System (Tor Vergata University). https://doi.org/10.32113/wcrj_20239_2682

Vancouver

Vanni G, Materazzo, M., Pellicciaro, M., Tacconi, et al. BREAST CANCER TREATMENT DE-ESCALATION: BREAKING THE SOUND BARRIER. Cineca Institutional Research Information System (Tor Vergata University). 2023. doi:10.32113/wcrj_20239_2682

BibTeX
@article{Vanni2023,
  author = {Vanni, Gianluca and Materazzo and M. and Pellicciaro and M. and Tacconi and F. and Faccini and A., B. and Longo, B. and Cervelli and V. and Buonomo and C., O.},
  title = {BREAST CANCER TREATMENT DE-ESCALATION: BREAKING THE SOUND BARRIER},
  journal = {Cineca Institutional Research Information System (Tor Vergata University)},
  year = {2023},
  doi = {10.32113/wcrj_20239_2682}
}
Kostenlos starten →